Brief: Aurinia Pharmaceuticals To Report Financial Results For The Three And Twelve Months Ended December 31, 2025
19/02/2026 11:42
Feb 19 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O: AURINIA PHARMACEUTICALS TO REPORT FINANCIAL RESULTS FOR THE THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2025 AND PROVIDE UPDATE ON RECENT BUSINESS PROGRESS ON FEBRUARY 26, 2026 Source text: ID:nBw67LHpja Further company coverage: AUPH.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death